Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06145451 · ClinicalTrials.gov registry record · NA
Connected Through Coaching for Flourishing Families
A NA study of Maltreatment by Parent, sponsored by University of Pittsburgh.
- Active
- Registry status
- NA
- Development phase
- 612
- Enrollment target
- 3
- Study locations
NCT06145451: Active NA study of Maltreatment by Parent, sponsored by University of Pittsburgh.
NCT06145451 is a NA study of Maltreatment by Parent that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 612 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06145451, a NA study of Maltreatment by Parent, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 612 participants
- Enrollment target
- 3
- Study locations
Study Summary
Despite the known association between the quality of participant relational engagement with service providers and clinical outcomes, limited studies have examined caregiver Relational Responsiveness (RR) as a mechanism to achieve maltreatment prevention program outcomes. Using a realist-informed mixed method approach, this study will examine RR's role in mediating the effects of a community-based maltreatment prevention program, the Family Success Network (FSN) on protective factors against maltreatment and the contexts within which RR's mediation effects are activated or inhibited.
Primary Outcome
The family protective factors will be assessed using the Protective Factors Survey - Second Edition (PFS-2). It is a 19-item, 5-point Likert scale assessing 1) Family Functioning/Resilience \[family's adaptive skills and strategies to persevere in times of crisis, 3 items, subscale score of 0-3\], 2) Nurturing/Attachment \[emotional bond and positive parent-child interactions, 4 items, subscale score of 0-4\]; 3) Concrete Supports \[perceived access to tangible goods and services, 2 items, subsc
Conditions Studied
Interventions
- BEHAVIORAL Family Success Network
Study Locations (3)
Ohio
- Case Western Reserve University - Cleveland
- Ohio State University - Columbus
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 612 participants |
| Start Date | 2024-08-16 |
| Est. Completion | 2026-09 |
| Phase | NA |
What the registry record for NCT06145451 still lists
NCT06145451 is an interventional study that assigns participants to a tested intervention. The registered 612 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Maltreatment by Parent appearing as the primary indexed condition, and to 1 intervention - of which Family Success Network is the first listed.
NCT06145451 reports a single indexed study location in Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06145451 about?
NCT06145451 is a clinical study titled "Connected Through Coaching for Flourishing Families". Despite the known association between the quality of participant relational engagement with service providers and clinical outcomes, limited studies have examined caregiver Relational Responsiveness (RR) as a mechanism to achieve maltreatment prevention program outcomes. Using a realist-informed mix...
What is the current status of trial NCT06145451?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 612 participants. The study started on 2024-08-16. Estimated completion is 2026-09.
What conditions does trial NCT06145451 study?
This clinical trial studies the following conditions: Maltreatment by Parent.
What interventions are being tested in trial NCT06145451?
The interventions under investigation include: Family Success Network (BEHAVIORAL).
Who is sponsoring clinical trial NCT06145451?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06145451 being conducted?
This trial has 3 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06145451's enrollment target sits among peer trials
612 161st of 2000 higher than 1,840 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04224493 · 612 participants · Phase 3
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
- NCT04590326 · 612 participants · Phase 1
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- NCT06266416 · 612 participants · NA
IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)
- NCT01810913 · 613 participants · Phase 2
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI